SSY GROUP (02005) obtained the drug production registration approval for Ammonium Valproate Tablet (0.5g) and Acesulfame Capsule (0.25g).

SSY GROUP (02005) announced that the group has obtained the drug production registration approval from the China National Medical Products Administration for Amoxicillin Tablets (0.5g), which belongs to the category 4 of chemical drugs, equivalent to passing consistency evaluation. It is the third domestic company to receive approval. Amoxicillin Tablets are mainly used for various types of bleeding caused by acute or chronic, localized or systemic primary hyperfibrinolysis. In addition, the group has also obtained the drug production registration approval from the National Medical Products Administration for Ezetimibe Capsules (0.25g), which belongs to the category 4 of chemical drugs, equivalent to passing consistency evaluation. It is the fourth domestic company to receive approval. Ezetimibe Capsules are mainly used to lower triglyceride levels in patients who cannot be adequately relieved by other treatments (such as statins or bile acid sequestrants).